| Models Name |
Cat.No. |
Animal Type |
Disease Area |
|
Skin hyperplasia, Ctsl knockout, in mouse (C57BL/6)
|
AB68680 |
mouse |
Hyperplasia |
|
Skin transplantation, skin allograft, in mouse (C57BL/6)
|
AB68681 |
mouse |
Transplantation |
|
Spasmolytic polypeptide-expressing metaplasia, DMP-777-induced, in mouse (C57BL/6)
|
AB68682 |
mouse |
Spasmolytic polypeptide-expressing metaplasia |
|
Spasmolytic polypeptide-expressing metaplasia, Wfdc2 knockout/DMP-777-induced, in mouse (C57BL/6)
|
AB68683 |
mouse |
Spasmolytic polypeptide-expressing metaplasia |
|
Spasmolytic polypeptide-expressing metaplasia, Wfdc2 knockout/L635-induced, in mouse (C57BL/6)
|
AB68684 |
mouse |
Spasmolytic polypeptide-expressing metaplasia |
|
Spasmolytic polypeptide-expressing metaplasia, Wfdc2 knockout/tamoxifen-induced, in mouse (C57BL/6)
|
AB68685 |
mouse |
Spasmolytic polypeptide-expressing metaplasia |
|
Spinal muscular atrophy, Smn +/- mutated, in mouse (C57BL/6)
|
AB68686 |
mouse |
Spinal muscular atrophy |
|
Spinal muscular atrophy, Smn1 mutated, in mouse (C57BL/6)
|
AB68687 |
mouse |
Spinal muscular atrophy |
|
Sporadic inclusion body myositis, transgenic (Tardbp), in mouse (C57BL/6)
|
AB68688 |
mouse |
Sporadic inclusion body myositis |
|
Staphylococcal epidermidis infection, Staphylococcus epidermidis (methicillin/rifampicin-resistant)-induced, in mouse (C57BL/6)
|
AB68689 |
mouse |
Infection,Staphylococcus epidermidis |